Pharmacological modulation of dopaminergic brain activity and its reflection in spectral frequencies of the rat electropharmacogram

Neuropsychobiology

Volumn 58, Issue 3-4, 2008, Pages 178-186

  Dimpfel, Wilfried ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Dopamine receptors; Electropharmacogram; Field potential; L DOPA; Tele Stereo EEG

Indexed keywords

DOPAMINE 1 RECEPTOR STIMULATING AGENT; LEVODOPA; QUINPIROLE; SULPIRIDE; TALIPEXOLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; ELECTRIC POTENTIAL; ELECTROENCEPHALOGRAM; FRONTAL CORTEX; HIPPOCAMPUS; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; RAT; RETICULAR FORMATION;

ANIMALS; AZEPINES; BRAIN; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; LEVODOPA; MICROELECTRODES; QUINPIROLE; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D2; SULPIRIDE;

EID: 58149359993     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000191124     Document Type: Article

References (34)

1. DeBoer P, Abercrombie ED: Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 receptor subtypes. J Pharmacol Exp Ther 1996;277:775-783
2. Hamidovic A, Kang UJ, de Wit H: Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psychopharmacol 2008;28:45-51.
3. Dimpfel W, Spüler M, Koch R, SchattonW: Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats. Neuropsychobiology 1987;18:212-218.
4. Kropf W, Kuschinsky K, Krieglstein J: Apomorphine-induced alterations in cortical EEG activity of rats: involvement of D-1 and D-2 dopamine receptors. Naunyn-Schmiedebergs Arch Pharmacol 1989;340:718-725.
5. Stahl D, Ferger B, Kuschinsky K: Sensitization to d-amphetamine after its repeated administration: evidence in EEG and behaviour. Naunyn-Schmiedebergs Arch Pharmacol 1997;356:335-340.
6. Vyazovskiy VV, Tobler I: Theta activity in the waking EEG is a marker of sleep propensity in the rat. Brain Res 2005;1050:64-71.
7. Vyazovskiy VV, Achermann P, Tobler I: Sleep homeostasis in the rat in the light and dark period. Brain Res Bull 2007;74:37-44.
8. Paxinos G, Watson C: The Rat Brain in Stereotactic Coordinates, New York, Academic Press, 1982.
9. Gottesmann C, Kirkham PA, LaCoste G, Rodrigues L, Amaud C: Automatic analysis of the sleep-waking cycle in the rat recorded by minature telemetry. Brain Res 1977;132:562-568.
10. Dimpfel W, Spüler M, Nickel B: Radioelectroencephalography (Tele-Stereo-EEG) in the rat as pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital. Neuropsychobiology 1986;16:163-168.
11. Entholzner E, Schneck HJ, Hargasser S, Hipp R, Tempel G: Electroencephalographic demonstration of central nervous system effects of different premedication regimes. Anaesthesist 1994;43:431-440.
12. Röhl JE, Harms L, Pommer W: Quantitative EEG findings in patients with chronic renal failure. Eur J Med Res 2007;12:173-178.
13. Ahrens H, Läuter J: Mehrdimensionale Varianzanalyse. Berlin, Academieverlag, 1974.
14. Dimpfel W, Schober F: Norepinephrine, EEG theta waves and sedation. Brain Pharmacol 2001;1:89-97.
15. Dimpfel W: Preclinical data base of pharmaco-specific rat EEG fingerprints (Tele-Stereo-EEG). Eur J Med Res 2003;8:199-207.
16. Kropf W, Kuschinsky K: Effects of stimulation of dopamine D1 receptors on the cortical EEG in rats: different influences by a blockade of D2 receptors and by an activation of putative autoreceptors. Neuropharmacology 1993;32:493-500.
17. Kropf W, Krieglstein J, Kuschinsky K: Effects of stimulation of putative dopamine autoreceptors on electroencephalographic power spectrum in comparison with effects produced by blockade of postsynaptic dopamine receptors in rats. Eur Neuropsychopharmacol 1992;2:467-474.
18. Kropf W, Kuschinsky K: Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors. Neuropharmacology 1991;30:953-960.
19. Arnsten AF, Cai JX, Steere JC, Goldman-Rakic PS: Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkey. J Neurosci 1995;15:3429-3439.
20. Sebban C, Zhang XQ, Tesolin-Decros B, Millan MJ, Spedding M: Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. Br J Pharmacol 1999;128:1045-1054.
21. Beaulieu J-M, Gainetdinov RR, Caron MG: The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends in Pharmacol Sci 2007;28:166-172.
22. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG: An Akt/beta-arrestin 2/PP2A signalling complex mediates dopaminergic neurotransmission and behavior. Cell 2005;122:262-273.
23. Alcantara AA, Chen V, Herring BE, Mendenhall JM, Berlanga ML: Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat. Brain Res 2003;986:22-29.
24. Dimpfel W: Pharmacological modulation of cholinergic brain activity and its reflection in special EEG frequency ranges from various brain areas in the freely moving rat (Tele-Stereo-EEG). Eur Neuropsychopharmacol 2005;15:673-682.
25. Gorell JM, Czarnecki B: Pharmacologic evidence for direct dopaminergic regulation of striatal acetylcholine release. Life Sci 1986;38:2239-2246.
26. Zhang L, Liu Y, Chen X: Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L-type channels in the rat. J Physiol 2005;568:469-481.
27. Pisani A, Bonsi P, Centonze D, Calabresi P, Bernardi G: Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J Neurosci 2000;20:1-6.
28. Van Koppen CJ, Kaiser B: Regulation of muscarinic acetylcholine receptor signaling. Pharmacol Ther 2003;98:197-220.
29. Fujishiro H, Umegaki H, Suzuki Y, Oohara-Kurotani S, Yamaguchi Y, Iguchi A: Dopamine D2 receptor plays a role in memory function: implications of dopamine-acetylcholine interaction in the ventral hippocampus. Psychopharmacology (Berl) 2005;182:253-261.
30. Hefco V, Yamada K, Hefco A, Hritcu L, Tiron A, Olariu A, Nabeshima T: Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats. Eur J Pharmacol 2003:474:227-232.
31. Marshall DL, Redfern PH, Wonnacott S: Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine treated rats. J Neurochem 1997;68:1511-1519.
32. Ferger B, Kropf W, Kuschinsky K: Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors. Psychopharmacology 1994;114:297-308.
33. Homan CN, Wenzel K, Suppan K, Ivanic G, Kriechbaum N, Crevenna R, Ott E: Sleep attacks in patients taking dopamine agonists: review. BMJ 2002;324:1483-1487.
34. Dimpfel W, Hoffmann JA: Electropharmacograms of rasagiline, aminoindane and selegiline in the freely moving rat. Parkinsonism Relat Disord 2007;13(suppl 2):102, P2.218.